Do males and females respond differently to the synthetic cannabinoid MMB-Fubinaca?
An animal study found that the synthetic cannabinoid MMB-Fubinaca produced significantly stronger behavioral and electrophysiological effects in male mice than female mice, all mediated through CB1 receptors.
Quick Facts
What This Study Found
MMB-Fubinaca activated CB1 receptors with much greater potency than the standard cannabinoid agonist WIN55,512-2 in both mouse and human brain tissue. In vivo, male mice showed significantly greater behavioral and electrophysiological responses than females, all dependent on CB1 receptor activity.
Key Numbers
MMB-Fubinaca showed much greater potency than WIN55,512-2 at CB1 receptors; male mice showed significantly greater behavioral and electrophysiological effects than females; effects were CB1 receptor-dependent
How They Did This
Combined behavioral, molecular, pharmacological, and electrophysiological approaches in mice, plus in vitro assays using mouse and human brain preparations. CB1 receptor-dependent effects confirmed using antagonists.
Why This Research Matters
Synthetic cannabinoids are a major public health concern and are far more potent than plant-derived THC. These sex-based differences in response could mean that risk assessments and emergency treatments may need to account for biological sex.
The Bigger Picture
Sex differences in cannabinoid pharmacology are increasingly well documented but rarely factored into public health messaging or clinical management of synthetic cannabinoid poisoning. This study adds to evidence that one-size-fits-all approaches may be inadequate.
What This Study Doesn't Tell Us
Animal study; findings may not directly translate to humans. Only one synthetic cannabinoid tested. Mechanisms underlying the sex difference were not fully elucidated.
Questions This Raises
- ?Do similar sex differences exist for other synthetic cannabinoids?
- ?Are the sex-dependent effects driven by hormonal factors, receptor density differences, or metabolism?
- ?Do these animal findings predict sex differences in human emergency presentations?
Trust & Context
- Key Stat:
- Males showed significantly stronger effects
- Evidence Grade:
- Well-designed animal study with multiple methodological approaches, but preclinical only.
- Study Age:
- Published in 2021; synthetic cannabinoid research continues to evolve rapidly.
- Original Title:
- Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.
- Published In:
- Addiction biology, 26(3), e12940 (2021)
- Authors:
- Oliveira da Cruz, José F(2), Ioannidou, Christina, Pagano Zottola, Antonio C(2), Muguruza, Carolina, Gomez-Sotres, Paula, Fernandez, Monica, Callado, Luis F, Marsicano, Giovanni, Busquets-Garcia, Arnau
- Database ID:
- RTHC-03395
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is MMB-Fubinaca?
MMB-Fubinaca (also called AMB-Fubinaca or FUB-AMB) is a synthetic cannabinoid that acts on CB1 receptors with much greater potency than THC or standard research cannabinoids.
Why did males respond more strongly?
The study confirmed the effects were CB1 receptor-dependent but did not fully explain why males were more sensitive. Sex differences in cannabinoid receptor density, hormonal modulation, or drug metabolism could contribute.
Read More on RethinkTHC
- THC-purity-potency-label-meaning
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- how-cannabis-products-made-concentrates-edibles
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
Cite This Study
https://rethinkthc.com/research/RTHC-03395APA
Oliveira da Cruz, José F; Ioannidou, Christina; Pagano Zottola, Antonio C; Muguruza, Carolina; Gomez-Sotres, Paula; Fernandez, Monica; Callado, Luis F; Marsicano, Giovanni; Busquets-Garcia, Arnau. (2021). Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.. Addiction biology, 26(3), e12940. https://doi.org/10.1111/adb.12940
MLA
Oliveira da Cruz, José F, et al. "Sex-dependent pharmacological profiles of the synthetic cannabinoid MMB-Fubinaca.." Addiction biology, 2021. https://doi.org/10.1111/adb.12940
RethinkTHC
RethinkTHC Research Database. "Sex-dependent pharmacological profiles of the synthetic cann..." RTHC-03395. Retrieved from https://rethinkthc.com/research/oliveira-2021-sexdependent-pharmacological-profiles-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.